Live Tumor Banking is the collection, growth and storage of your living tumor tissue.
Tumors are typically stored through processes that kill the tumor cells and limit future testing options. Live Tumor Banking preserves and stores your living tumor as taken from your body AND utilizes a new process called “tumor grafting” to grow your living tumor in a manner similar to the way it grows in your body. This “Personalized Tumorgraft” process enables future testing that may help guide your treatment.
Cancers are unique to each individual. Live Tumor Banking and testing is a novel process that provides physicians with more information about your tumor and its likely response to a range of treatment options. This personalized approach to cancer treatment is designed to identify therapies that are specifically suited to your cancer.
Additionally, cancer risk is sometimes inherited; certain gene variations and mutations may be passed to future generations. By preserving your live tumor for future testing, you’re making a choice that could benefit a family member by making your tumor tissue available for all kinds of testing well into the future.
Why bank your living tumor?
Simply put, banking your live tumor preserves and expands your treatment options; it makes testing possible that may identify the best treatment drug(s) for you.
Your treatment plan is typically chosen by following the current standard of care; a one-size-fits-all approach based on results from large studies of patients with a similar type of cancer. However, most of these studies don’t take into account the unique molecular cancer type of the individual patients. Explained another way, cancer treatment today is most often based on treating you with a drug that worked for some patients in a large study, but didn’t work for many patients, and it may not work for you.
Live Tumor Banking goes beyond the current standard of care by helping physicians customize treatment based on each individual’s unique cancer. The Live Tumor Banking program makes it possible to characterize your tumor, perform specialized testing and evaluate the benefit of rapidly emerging technologies. This approach is intended to assist your physician in future treatment decisions by providing them the results from testing multiple drugs and drug combinations on your live tumor. Such testing is showing promise in predicting what drugs will work and won’t work for you.
Global leaders in oncology have successfully leveraged this new technology through Champions Biotechnology to treat their patients. Once available only to some of the world’s wealthiest individuals, this technology is now available to you.
What types of cancer have been banked by Champions Biotechnology?
Champions and its collaborators have successfully banked hundreds of Tumorgrafts and have banked all major cancer types as well as many rare tumors.